TrialJournal of Parkinson's disease2021

Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion.

Matthew Rosebraugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.